PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
PharmaCyte Biotech, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.34+0.00 (+0.53%)
Close on Oct 19, 2026
- Market cap
- $3.67M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 10, 2021(first seen in filings) | 1-for-1500 reverse | Earlier per-share figures multiplied by 1500 |
| Jul 12, 2021 | 1-for-1550 reverse | Earlier per-share figures multiplied by 1550 |